For Immediate Release

Contact:  Jay Zager

June 23, 2005

(860) 644-1551



GERBER SCIENTIFIC REPORTS FISCAL 2005 YEAR AND FOURTH QUARTER RESULTS

SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported a loss for the three months ended April 30, 2005 of $4.8 million, or $0.21 per diluted share, on revenue of $133.4 million compared with earnings of $3.6 million, or $0.16 per diluted share, on revenue of $136.7 million for the three months ended April 30, 2004.

For the fiscal year ended April 30, 2005, the Company reported a loss of $5.6 million, or $0.25 per diluted share, on revenue of $517.3 million compared with earnings of $5.5 million, or $0.25 per diluted share, on revenue of $516.8 million for the year ended April 30, 2004.

Included in the operating results for the three and twelve months ended April 30, 2005 were pre-tax charges amounting to $5.6 million ($0.16 per diluted share) and $10.5 million ($0.31 per diluted share), respectively, representing inventory write-downs associated with Gerber Coburn and Spandex business re-engineering initiatives, product discontinuation costs, and other adjustments. Also included in the operating results for the three and twelve months ended April 30, 2005 were external Sarbanes-Oxley compliance costs of $2.3 million ($.07 per diluted share) and $3.4 million ($0.10 per diluted share), respectively. Included in the operating results for the three and twelve month periods ended April 30, 2004 were pre-tax charges amounting to $0.9 million ($0.03 per diluted share) and $1.4 million ($0.04 per diluted share), respectively, representing inventory write-downs associated with business re-engineering initiatives.

Foreign currency translation had the effect of increasing revenue by approximately $5.1 million and $20.3 million in the fiscal 2005 fourth quarter and full year, respectively, over the fiscal 2004 comparable periods.

Gerber Scientific president and chief executive officer, Marc T. Giles, said: "The fundamental drivers of our business were in line with our expectations for the fourth quarter. Orders, revenue, and backlog were the highest for the fiscal year. New product introductions, including the GERBER EDGE FX and GERBER SOLARA in the Sign Making and Specialty Graphics segment and the DTL Generator in the Ophthalmic Lens Processing segment, contributed to the increases. During the fourth quarter, our operating results were adversely affected by significant costs primarily associated with Sarbanes-Oxley compliance, a product discontinuation in the Sign Making and Specialty Graphics segment, and inventory write-downs related to Gerber Coburn and Spandex business re-engineering. While elements of our turnaround strategy resulted in substantial charges in fiscal 2005, we finished the consolidation of our manufacturing operations and the implementation of SAP throughout most of the Company in the year. We anticipate that these achievements and further business process improvements will result in operating leverage as traction for our new products develops."

The Company had total debt of $45.7 million at April 30, 2005 compared with total debt of $45.2 million at January 31, 2005. Within this overall debt level, the Company reduced its higher cost term debt by almost half, from $18.5 million at January 31, 2005 to $10.3 million at April 30, 2005. Based on the fourth quarter operating results and a scheduled tightening of financial covenant compliance requirements under the Company's revolving credit and term loan agreements, the Company was not in compliance with certain financial covenants in those agreements at April 30, 2005. On June 21, 2005, the lenders under the revolving credit and term loan agreements waived compliance with those covenants at April 30, 2005. The Company is currently in discussions with its lenders to amend its credit agreements going forward, which it expects to complete in the near term. The Company believes that borrowings under its revolving credit facility, operating cash flows, and cash on hand will be sufficient to support its near term working capital and other cash requirements.

For additional information, including segment and order entry information, please see our annual report on Form 10-K for the year ended April 30, 2005, to be filed with the Securities and Exchange Commission.

About Gerber Scientific, Inc.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products and Spandex Ltd., Gerber Technology, and Gerber Coburn.

Forward-looking Statements:

Statements contained in this news release regarding the Company's expected financial condition, revenue, cash flow, operating results, restructuring and other charges, cost savings, operational efficiencies, debt reduction, other potential benefits of its turnaround initiatives, business strategy and other planned events and expectations are forward-looking statements that involve risks and uncertainties. Actual future results or events may differ materially from these forward-looking statements. Readers are referred to the documents filed by the Company with the Securities and Exchange Commission, including the Company's annual report on Form 10-K for the fiscal year ended April 30, 2004 and subsequently filed quarterly and current reports, for a discussion of important risks that could cause actual results to differ from those contained or implied in the forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments that could affect the Company's pricing decisions and the timing of product introductions, any failure by the Company to implement its restructuring plan successfully, rapid technological advances that could cause the Company's inventory to exceed its needs or become obsolete, the Company's reliance on manufacturers or suppliers to supply inventory to the Company's specifications in a timely and cost effective manner, non-recurring orders from significant customers, delays caused by facility relocations, the elimination of apparel trade quotas, fluctuations in currency exchange rates and international economic conditions that could cause the Company's financial results to be volatile, product liability claims, regulatory changes that could increase costs, the Company's indebtedness, compliance with financial covenants associated with the Company's primary credit agreements, any failure to enhance and diversify Sign Making and Specialty Graphics segment product lines, a potential loss of market focus as the Company seeks to improve operating efficiencies, and the Company's increased focus on larger wholesale optical laboratories. The Company expressly disclaims any obligation to update any of these forward-looking statements.

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


Three Months Ended
                April 30,              

Years Ended
               April 30,             

             

In thousands (except per share amounts)

     2005 

 

     2004(1) 

     2005 

 

     2004(1)  

             

Revenue:

           

     Product sales

$ 118,283 

 

$ 121,481 

$ 458,055 

 

$ 460,466 

     Service sales

    15,149 

 

    15,203 

   59,267 

 

   56,350 

  133,432 

  136,684 

 517,322 

 516,816 

Costs and Expenses:

           

     Cost of products sold

87,349 

 

84,736 

323,392 

 

319,468 

     Cost of services sold

10,602 

 

10,335 

39,236 

 

35,255 

     Selling, general and administrative

34,875 

 

28,381 

127,249 

 

115,910 

     Research and development

6,307 

 

6,560 

25,037 

 

25,207 

     Restructuring charges

         437 

 

          ---  

     3,031 

 

     2,482 

 

  139,570 

 

  130,012 

 517,945 

 

 498,322 

Operating (loss) income

(6,138)

 

6,672 

(623)

 

18,494 

             

Other income (expense), net

16 

 

(698)

(2,584)

 

(4,206)

Interest expense

    (1,421)

 

    (2,757)

    (6,747)

 

  (12,085)

(Loss) earnings before income taxes

(7,543)

 

3,217 

(9,954)

 

2,203 

(Benefit) for income taxes

    (2,754)

 

       (337)

    (4,393)

 

   (3,331)

Net (loss) earnings

$   (4,789)

 

$    3,554 

$   (5,561)

 

$   5,534 

 

=======

 

=======

=======

 

=======

(Loss) earnings per share of common stock:

           

     Basic

$      (.21) 

 

$       .16 

$       (.25)

 

$       .25 

     Diluted

       (.21) 

 

      .16 

      (.25)

 

      .25 

             

Average shares outstanding:

           

     Basic

22,278 

 

22,216 

22,261 

 

22,197

     Diluted

22,278 

 

22,440 

22,261 

 

22,393

(1) Certain reclassifications have been made to the prior year amounts to conform to the fiscal 2005 presentation.

 

GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
CONSOLIDATED SUMMARY BALANCE SHEETS

(Unaudited)


In thousands

   April 30,         2005     

 

April 30,      2004    

Assets:

     

Current Assets:

     

     Cash and cash equivalents

$    6,148 

 

$    6,371 

     Accounts receivable, net

89,800 

 

90,453 

     Inventories

52,363 

 

49,696 

     Prepaid expenses and other current assets

    13,851 

 

    11,307 

 

  162,162 

 

  157,827 

Property, Plant and Equipment, Net

    39,923 

 

    42,574 

Intangible Assets, Net

    59,399 

 

    59,010 

Deferred Income Taxes

29,788 

 

19,738 

Other Assets

      6,014 

 

      7,737 

 

$ 297,286 

 

$ 286,886 

 

=======

 

=======

Liabilities and Shareholders' Equity:

     

Current Liabilities:

     

     Current maturities of long-term debt

$  29,482 

 

$  12,509 

     Accounts payable

47,023 

 

43,397 

     Accrued and other liabilities

    57,052 

 

    46,135 

 

  133,557 

 

  102,041 

Noncurrent Liabilities:

     

     Long-term debt

   16,260 

 

   46,512 

     Other long-term liabilities

   31,663 

 

   20,731 

 

   47,923 

 

   67,243 

Shareholders' Equity

  115,806 

 

 117,602 

 

$ 297,286 

 

$ 286,886 

 

=======

 

=======